Adiposity distribution influences circulating adiponectin levels

Translational Research

Volumn 164, Issue 4, 2014, Pages 270-277

  Guenther, Mitchell ^a   James, Roland ^a   Marks, Jacqueline ^a   Zhao, Shi ^a   Szabo, Aniko ^a   Kidambi, Srividya ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

CT = computed tomography; HDL C = high density lipoprotein cholesterol; HOMA = homeostasis model assessment; IL = interleukin; IR = insulin resistance; LDL C = low density lipoprotein cholesterol; SAT = subcutaneous adipose tissue; SD = standard deviation; TNF = tumor necrosis factor ; VAT = visceral adipose tissue

Indexed keywords

ADIPONECTIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ABDOMINAL RADIOGRAPHY; ANTHROPOMETRY; ARTICLE; BODY FAT; BODY MASS; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FAT FREE MASS; FAT MASS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INTRAABDOMINAL FAT; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NORTHERN EUROPEAN; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; SUBCUTANEOUS FAT; WAIST CIRCUMFERENCE; WEIGHT REDUCTION; ADULT; AGING; BLOOD; MIDDLE AGED; OBESITY; PHYSIOLOGY;

ADIPONECTIN; ADIPOSITY; ADULT; AGING; BODY MASS INDEX; FEMALE; HUMANS; MALE; MIDDLE AGED; SEX FACTORS; TRIGLYCERIDES;

EID: 84908044389     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2014.04.008     Document Type: Article

References (55)

1. K.E. Wellen, and G.S. Hotamisligil Inflammation, stress, and diabetes J Clin Invest 115 2005 1111 1119
2. P. Hossain, B. Kawar, and M. El Nahas Obesity and diabetes in the developing world - a growing challenge N Engl J Med 356 2007 213 215
3. H.E. Lebovitz The relationship of obesity to the metabolic syndrome Int J Clin Pract Suppl 134 2003 18 27
4. R.S. Ahima, and J.S. Flier Adipose tissue as an endocrine organ Trends Endocrinol Metab 11 2000 327 332
5. A.T. Turer, and P.E. Scherer Adiponectin: mechanistic insights and clinical implications Diabetologia 55 2012 2319 2326
6. F. Ziemke, and C.S. Mantzoros Adiponectin in insulin resistance: lessons from translational research Am J Clin Nutr 91 2010 258S 261S
7. Y. Okauchi, K. Kishida, and T. Funahashi Changes in serum adiponectin concentrations correlate with changes in BMI, waist circumference, and estimated visceral fat area in middle-aged general population Diabetes Care 32 2009 e122
8. M. Cnop, P.J. Havel, and K.M. Utzschneider Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex Diabetologia 46 2003 459 469
9. J.R. Cook, and R.K. Semple Hypoadiponectinemia - cause or consequence of human "insulin resistance"? J Clin Endocrinol Metabol 95 2010 1544 1554
10. Y. Arita, S. Kihara, and N. Ouchi Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity Biochem Biophys Res Commun 257 1999 79 83
11. A.T. Turer, A. Khera, and C.R. Ayers Adipose tissue mass and location affect circulating adiponectin levels Diabetologia 54 2011 2515 2524
12. A.P. Doumatey, A.R. Bentley, J. Zhou, H. Huang, A. Adeyemo, and C.N. Rotimi Paradoxical hyperadiponectinemia is associated with the metabolically healthy obese (MHO) phenotype in African Americans J Endocrinol Metab 2 2012 51 65
13. E.A. Sims Are there persons who are obese, but metabolically healthy? Metabolism 50 2001 1499 1504
14. A.H. Kissebah, and G.R. Krakower Regional adiposity and morbidity Physiol Rev 74 1994 761 811
15. A.H. Kissebah, G.E. Sonnenberg, and J. Myklebust Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome Proc Natl Acad Sci U S A 97 2000 14478 14483
16. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
17. A.G. Comuzzie, M.E. Tejero, and T. Funahashi The genes influencing adiponectin levels also influence risk factors for metabolic syndrome and type 2 diabetes Hum Biol 79 2007 191 200
18. N.C. dupont, K. Wang, P.D. Wadhwa, J.F. Culhane, and E.L. Nelson Validation and comparison of luminex multiplex cytokine analysis kits with ELISA: determinations of a panel of nine cytokines in clinical sample culture supernatants J Reprod Immunol 66 2005 175 191
19. O.L. Svendsen, J. Haarbo, B.L. Heitmann, A. Gotfredsen, and C. Christiansen Measurement of body fat in elderly subjects by dual-energy x-ray absorptiometry, bioelectrical impedance, and anthropometry Am J Clin Nutr 53 1991 1117 1123
20. D.J. Evans, R.G. Hoffmann, R.K. Kalkhoff, and A.H. Kissebah Relationship of body fat topography to insulin sensitivity and metabolic profiles in premenopausal women Metabolism 33 1984 68 75
21. G.A. Borkan, S.G. Gerzof, A.H. Robbins, D.E. Hults, C.K. Silbert, and J.E. Silbert Assessment of abdominal fat content by computed tomography Am J Clin Nutr 36 1982 172 177
22. H. Kvist, B. Chowdhury, U. Grangard, U. Tylen, and L. Sjostrom Total and visceral adipose-tissue volumes derived from measurements with computed tomography in adult men and women: predictive equations Am J Clin Nutr 48 1988 1351 1361
23. P.G. Nagy, and C.R. Wilson Knowledge-based segmentation of abdominal CT images using active contour deformable models Med Phys 23 1996 6
24. C. Usui, M. Asaka, and H. Kawano Visceral fat is a strong predictor of insulin resistance regardless of cardiorespiratory fitness in non-diabetic people J Nutr Sci Vitaminol (Tokyo) 56 2010 109 116
25. A. Misra, A. Garg, N. Abate, R.M. Peshock, J. Stray-Gundersen, and S.M. Grundy Relationship of anterior and posterior subcutaneous abdominal fat to insulin sensitivity in nondiabetic men Obes Res 5 1997 93 99
26. M.B. Snijder, J.M. Dekker, and M. Visser Associations of hip and thigh circumferences independent of waist circumference with the incidence of type 2 diabetes: the Hoorn Study Am J Clin Nutr 77 2003 1192 1197
27. L.B. Tanko, Y.Z. Bagger, P. Alexandersen, P.J. Larsen, and C. Christiansen Peripheral adiposity exhibits an independent dominant antiatherogenic effect in elderly women Circulation 107 2003 1626 1631
28. T. McLaughlin, C. Lamendola, A. Liu, and F. Abbasi Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity J Clin Endocrinol Metab 96 2011 E1756 E1760
29. P.E. Scherer, S. Williams, M. Fogliano, G. Baldini, and H.F. Lodish A novel serum protein similar to C1q, produced exclusively in adipocytes J Biol Chem 270 1995 26746 26749
30. K. Hara, M. Horikoshi, and T. Yamauchi Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome Diabetes Care 29 2006 1357 1362
31. N. Zhu, J.S. Pankow, and C.M. Ballantyne High-molecular-weight adiponectin and the risk of type 2 diabetes in the ARIC study J Clin Endocrinol Metab 95 2010 5097 5104
32. H. Motoshima, X. Wu, and M.K. Sinha Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone J Clin Endocrinol Metab 87 2002 5662 5667
33. S. Matsui, T. Yasui, and A. Tani Association of circulating adiponectin with testosterone in women during the menopausal transition Maturitas 73 2012 255 260
34. J. Cui, X. Wu, J. Andrel, and B. Falkner Relationships of total adiponectin and molecular weight fractions of adiponectin with free testosterone in African men and premenopausal women J Clin Hyperten 12 2010 957 963
35. L. Frederiksen, K. Hojlund, and D.M. Hougaard Testosterone therapy decreases subcutaneous fat and adiponectin in aging men Eur J Endocrinol 166 2012 469 476
36. S.T. Page, K.L. Herbst, and J.K. Amory Testosterone administration suppresses adiponectin levels in men J Androl 26 2005 85 92
37. A.D. Seftel Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes J Urol 174 2005 1045 1046
38. A. Xu, K.W. Chan, and R.L.C. Hoo Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes J Biol Chem 280 2005 18073 18080
39. J.G. Woo, L.M. Dolan, S.R. Daniels, E. Goodman, and L.J. Martin Adolescent sex differences in adiponectin are conditional on pubertal development and adiposity Obes Res 13 2005 2095 2101
40. C. De Maddalena, S. Vodo, A. Petroni, and A.M. Aloisi Impact of testosterone on body fat composition J Cell Physiol 227 2012 3744 3748
41. G. Ntaios, N.K. Gatselis, K. Makaritsis, and G.N. Dalekos Adipokines as mediators of endothelial function and atherosclerosis Atherosclerosis 227 2013 216 221
42. F. Marra, and C. Bertolani Adipokines in liver diseases Hepatology 50 2009 957 969
43. M.N. Vansaun Molecular pathways: adiponectin and leptin signaling in cancer Clin Cancer Res 19 2013 1926 1932
44. T. Yamauchi, J. Kamon, and Y. Ito Cloning of adiponectin receptors that mediate antidiabetic metabolic effects Nature 423 2003 762 769
45. M. Bjursell, A. Ahnmark, and Y.M. Bohlooly Opposing effects of adiponectin receptors 1 and 2 on energy metabolism Diabetes 56 2007 583 593
46. T. Yamauchi, Y. Nio, and T. Maki Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions Nat Med 13 2007 332 339
47. Y. Okamoto, S. Kihara, and N. Ouchi Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice Circulation 106 2002 2767 2770
48. Y. Okamoto, Y. Arita, and M. Nishida An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls Horm Metab Res 32 2000 47 50
49. Y. Arita, S. Kihara, and N. Ouchi Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell Circulation 105 2002 2893 2898
50. M. Hayashi, R. Shibata, and H. Takahashi Association of adiponectin with carotid arteriosclerosis in predialysis chronic kidney disease Am J Nephrol 34 2011 249 255
51. N. Ouchi, S. Kihara, and Y. Arita Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway Circulation 102 2000 1296 1301
52. R. Shibata, N. Ouchi, and M. Ito Adiponectin-mediated modulation of hypertrophic signals in the heart Nat Med 10 2004 1384 1389
53. R. Shibata, K. Sato, and D.R. Pimentel Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms Nat Med 11 2005 1096 1103
54. G. Hao, W. Li, and R. Guo Serum total adiponectin level and the risk of cardiovascular disease in general population: a meta-analysis of 17 prospective studies Atherosclerosis 228 2013 29 35
55. H. Yaghootkar, C. Lamina, and R.A. Scott Mendelian randomization studies do not support a causal role for reduced circulating adiponectin levels in insulin resistance and type 2 diabetes Diabetes 62 2013 3589 3598